.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Teva
Chubb
McKesson
Queensland Health
Daiichi Sankyo
Baxter
McKinsey
QuintilesIMS

Generated: November 18, 2017

DrugPatentWatch Database Preview

Sevoflurane - Generic Drug Details

« Back to Dashboard

What are the generic sources for sevoflurane and what is the scope of sevoflurane freedom to operate?

Sevoflurane
is the generic ingredient in three branded drugs marketed by Halocarbon Prods, Piramal Critical, Abbvie, Shanghai Hengrui, and Baxter Hlthcare, and is included in five NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sevoflurane has ninety-seven patent family members in thirty-seven countries.

There are five drug master file entries for sevoflurane. Five suppliers are listed for this compound.

Pharmacology for sevoflurane

Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Critical
SOJOURN
sevoflurane
LIQUID;INHALATION077867-001May 2, 2007ANRXNoNo► Subscribe► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes► Subscribe► SubscribeY► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes► Subscribe► SubscribeY► Subscribe
Shanghai Hengrui
SEVOFLURANE
sevoflurane
LIQUID;INHALATION203793-001Nov 3, 2015ANRXNoNo► Subscribe► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes► Subscribe► SubscribeY► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes► Subscribe► SubscribeY► Subscribe
Halocarbon Prods
SEVOFLURANE
sevoflurane
LIQUID;INHALATION078650-001Nov 19, 2007ANRXNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
SEVOFLURANE
sevoflurane
LIQUID;INHALATION075895-001Jul 2, 2002ANRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sevoflurane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995► Subscribe► Subscribe
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: sevoflurane

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,677,492 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid► Subscribe
6,558,679 Container for an inhalation anesthetic► Subscribe
6,162,443 Container for an inhalation anesthetic► Subscribe
6,083,514 Polymethylpentene container for an inhalation anesthetic► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sevoflurane

Country Document Number Estimated Expiration
Czech Republic295380► Subscribe
China1321958► Subscribe
Yugoslavia40800► Subscribe
Czech Republic297092► Subscribe
Japan3524060► Subscribe
Taiwan470643► Subscribe
China1560003► Subscribe
Japan2001187729► Subscribe
Germany69906929► Subscribe
China1288368► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Cantor Fitzgerald
Chinese Patent Office
McKesson
McKinsey
Teva
Cerilliant
Medtronic
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot